Data may lead to better treatment
Know Your Tumor initiative matches treatments with patients
An international consensus statement on a subtype of a rare disease
How to care for patients with this rare, complex disease
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Tumor factors are more significant, says new study
Study includes largest cohort to date
Multigene panel testing valuable regardless of age, cancer history
Increased invasive disease-free survival, disease-free survival and overall survival
Prescreening for clots also effective
Should lead to better treatment
Advertisement
Advertisement